Start here: the hormone that meets demand
Cortisol is the hormone that helps your body rise to the demands of being awake and active, raising energy availability, steadying blood pressure, and tuning the immune response. When there is too little of it, the result can be deep fatigue, low blood pressure, and a flattened capacity to cope, physically and emotionally.
Several long COVID studies report cortisol on the low side, which makes the systems that depend on it a reasonable place to look for some of the exhaustion and low mood. This page is about one specific proposed route to that shortfall.
The autoantibody route
The chain that controls cortisol runs from the brain, which releases a signal called ACTH, to the adrenal glands, which respond by making cortisol. The proposal here is that the immune system produces ACTH autoantibodies, interfering with that signal, alongside a critical-illness-related corticosteroid insufficiency.1
If the ACTH signal is blunted, the adrenal glands make less cortisol even when the body needs more. It is a mechanistically coherent idea, which is why it is being explored, even though the evidence remains early.
Where it feeds in
This route is one input into the broader HPA-axis cortisol dysregulation seen in long COVID, the disturbance of the brain-adrenal stress system that governs cortisol's daily rhythm. The autoantibody and critical-illness mechanisms are proposed ways that system's output can fall.
Placed in context, it connects the endocrine thread to the fatigue and mood threads: if cortisol is low, the energy and mood systems that rely on it suffer, which is part of why the endocrine and mood clusters overlap.
How strong the evidence is
The honest grading is low and the audit emerging. The cortisol findings themselves are mixed across studies, partly because cortisol varies through the day and single measurements can mislead, and the specific autoantibody route is one hypothesis among several rather than an established cause.
So this belongs firmly in the developing-science column. It is a plausible piece of the puzzle that deserves study, not a confirmed mechanism on which to base decisions.
lowemergingcortisol findings mixed
What it means for testing
Because the route is unproven and cortisol is tricky to measure, this is not yet something that translates into a routine test or treatment. Cortisol testing exists, but interpreting it requires attention to timing and the daily rhythm, and abnormal results need careful clinical context rather than self-interpretation.
If genuine adrenal insufficiency is suspected, that is a specific medical question for an endocrinologist, distinct from this proposed long-COVID mechanism. The mechanism is a reason to keep the endocrine system in view, not a basis for assuming a cortisol problem.
Why it still matters
Even as an early hypothesis, this mechanism is useful because it offers a concrete, physical route to symptoms, fatigue and low mood, that are often dismissed. It locates part of the exhaustion in hormone biology rather than in character.
It also points research somewhere testable: if a subgroup genuinely has autoantibody-driven low cortisol, that would be both identifiable and potentially treatable. That possibility is what makes the thread worth following despite its current thinness.
What we don't know
Honest about the edges of the evidence. These are open questions, not settled answers.
- Whether ACTH autoantibodies genuinely drive low cortisol in a long COVID subgroup.
- How common a real cortisol deficit is, given mixed and timing-sensitive measurements.
- Whether correcting cortisol would improve fatigue and mood.
- How this route relates to the broader HPA-axis disruption.
- How to identify the people, if any, who are genuinely cortisol-deficient.
- Whether the critical-illness mechanism resolves as people recover.
What this means for you
If your fatigue and low mood feel hormonal, deep, physical, demand-related, the cortisol systems are a reasonable thing to have in view, and this autoantibody route is one early idea for why cortisol can run low after COVID. It locates part of the exhaustion in biology rather than in willpower.
Keep expectations proportionate, though: the evidence is early and cortisol is genuinely hard to measure, so this is not yet a test to chase or a treatment to start. If real adrenal insufficiency is suspected, that is a specific question for an endocrinologist, separate from this developing long-COVID hypothesis.
And resist turning an early hypothesis into a shopping list. The cortisol systems are worth keeping in view, but the evidence here is thin, cortisol is genuinely hard to measure, and abnormal results need an endocrinologist's interpretation rather than self-diagnosis. The value of this mechanism right now is that it locates part of the exhaustion in hormone biology, which is a reason for patience and proper testing, not for unproven supplements aimed at the adrenal glands. If a real deficit is found it is treatable, which is itself a reason to test properly with an endocrinologist rather than guess at it from symptoms alone.
References
Each reference links to the source on PubMed, PMC, or the publisher.